IL188691A0 - Compositions and methods to control angiogenesis with cupredoxins - Google Patents

Compositions and methods to control angiogenesis with cupredoxins

Info

Publication number
IL188691A0
IL188691A0 IL188691A IL18869108A IL188691A0 IL 188691 A0 IL188691 A0 IL 188691A0 IL 188691 A IL188691 A IL 188691A IL 18869108 A IL18869108 A IL 18869108A IL 188691 A0 IL188691 A0 IL 188691A0
Authority
IL
Israel
Prior art keywords
cupredoxins
compositions
methods
control angiogenesis
angiogenesis
Prior art date
Application number
IL188691A
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of IL188691A0 publication Critical patent/IL188691A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
IL188691A 2005-07-19 2008-01-09 Compositions and methods to control angiogenesis with cupredoxins IL188691A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
PCT/US2006/027940 WO2007024368A2 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Publications (1)

Publication Number Publication Date
IL188691A0 true IL188691A0 (en) 2008-08-07

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188691A IL188691A0 (en) 2005-07-19 2008-01-09 Compositions and methods to control angiogenesis with cupredoxins

Country Status (10)

Country Link
EP (1) EP1904081A4 (en)
JP (1) JP2009502797A (en)
KR (1) KR20080034905A (en)
AU (1) AU2006284490A1 (en)
BR (1) BRPI0615555A2 (en)
CA (1) CA2615560A1 (en)
IL (1) IL188691A0 (en)
MX (1) MX2008000993A (en)
NO (1) NO20080829L (en)
WO (1) WO2007024368A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
BRPI0714987A2 (en) * 2006-09-14 2013-07-30 Trutees Of The University Of Illinoi Board Of cupredoxin cancer prevention compositions and methods
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
AU2005327535A1 (en) * 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof
CA2608398A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
CA2607739A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating malaria with cupredoxin and cytochrome
EP1888106A4 (en) * 2005-05-20 2009-01-14 Univ Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Also Published As

Publication number Publication date
MX2008000993A (en) 2008-03-19
JP2009502797A (en) 2009-01-29
WO2007024368A2 (en) 2007-03-01
BRPI0615555A2 (en) 2009-07-14
WO2007024368A3 (en) 2007-10-11
EP1904081A2 (en) 2008-04-02
NO20080829L (en) 2008-04-02
AU2006284490A8 (en) 2008-02-28
CA2615560A1 (en) 2007-03-01
AU2006284490A1 (en) 2007-03-01
EP1904081A4 (en) 2008-12-03
KR20080034905A (en) 2008-04-22

Similar Documents

Publication Publication Date Title
GB2469243B (en) Improvements in or relating to ablutionary installations
ZA200804295B (en) Shading composition
EP2086318A4 (en) Neuroprotective compositions and methods
EP2101731A4 (en) Endoxifen methods and compositions
EP2088865A4 (en) Guggulphospholipid methods and compositions
GB0617171D0 (en) Novel compositions and methods
GB0622399D0 (en) Novel compositions and uses thereof
ZA201001305B (en) Pyrone analog compositions and methods
GB0519717D0 (en) Improvements in or relating to devices
GB2425531B (en) Cement compositions with aplite
GB0520931D0 (en) Improvements in or relating to compositions
ZA200802220B (en) Improvements in or relating to compositions
EP1998753A4 (en) High-deposition compositions and uses thereof
ZA200800503B (en) Compositions and methods to control angiogenesis with cupredoxins
IL188691A0 (en) Compositions and methods to control angiogenesis with cupredoxins
GB0622400D0 (en) Novel compositions and uses thereof
GB0600336D0 (en) Composition and uses thereof
EP2010141A4 (en) High-deposition compositions and uses thereof
EP1889173A4 (en) Subscribing to content
GB0500224D0 (en) Improvements in or relating to ablutionary installations
GB0614252D0 (en) Improvements to building elements
GB0504185D0 (en) Improved glazing composition and uses thereof
GB0500847D0 (en) Claims to be made
GB0517718D0 (en) Further improvement to brikmat
GB0615913D0 (en) Herbal composition